17. Theo
Chapter 17
Theo
Three days after Aurora’s fall, and I still taste ash in the air. Finn says it’s just in my head, but that doesn’t make it less real. My heat has settled now as I move through Omega Guardians’ medical wing.
I’ve had heats before. But never like this. Never surrounded by people who saw all of me and stayed. In my family’s villa outside Naples, I was meant to be admired and owned. Here, I’m just Theo. Artist, healer, part of something real.
The private recovery suite Quinn arranged feels both sterile and sacred—a contradiction, but somehow right. Our pack has transformed it into something like home.
Morning light filters through reinforced windows, casting patterns across sleeping forms still tangled together despite recommendations for separate recovery. The beep of monitors plays rhythm to their breathing.
Some instincts override professional advice. Being together heals wounds science can’t measure, a truth my grandmother whispered while preparing me for arranged meetings. Family is medicine, she would say.
I adjust Finn’s IV, then check the latest results from Mona’s treatment protocol. The formula Roman injected him with continues its unpredictable course—not lethal, thanks to his previous exposure, but creating biological anomalies that have Mona buzzing with scientific curiosity. His skin still holds a slight fever, his earl grey scent carrying chemical notes no standard treatment would recognize.
His mind works even in sleep, fingers twitching through dream-calculations like a pianist practicing without a keyboard. The data program he designed continues scrolling on his tablet, tracking Sterling formula distribution and recall statistics. Always working, even in recovery.
I check his temperature, and his breathing smooths under my touch.
Ryker sleeps closest to the door—tactical habit unchanged despite security that would impress even him. His shoulder wound is healing well, though he stubbornly refuses pain meds that might dull his vigilance.
His cedar and steel scent carries protective notes even in sleep. Even now, his body stays oriented toward potential threats, one hand near a concealed weapon.
I’ve learned to change his dressings without disrupting his defensive position—working around his alpha nature rather than fighting it.
Jinx sprawls in apparent chaos that’s actually perfect defensive positioning. His injuries were mostly surface—bruises, cuts, one cracked rib—but his exhaustion runs deeper.
The violence he channeled at Aurora took a psychological toll he’s still processing. His expression softens only in sleep, the predatory edges temporarily smoothed.
His cherry tobacco scent has mellowed from combat-ready to something deeper that emerges only when the pack is safely gathered.
And Cayenne—fierce, brilliant, impossible Cayenne—curls between them like she’s always belonged. Like she’s the final piece that makes everything work.
On the surface, she looks fine—tired, scraped up. Nothing serious. But beneath that skin? Her body’s still fighting. Sterling’s DNA mixed with virus fallout and whatever blocker she took.
Mona tracks it like a puzzle she has to solve, a complex equation needing her particular brand of genius.
And her scent... her scent. Still lemon and ozone, sharp and clean—but with something new underneath. Something deeper. It hits me hard, triggering instincts I shouldn’t have for a beta.
But that’s Cayenne. She’s never fit inside anyone’s definitions, always spilling beyond designation lines, just as I refused to become the perfect omega son my family tried to shape.
The sight of them together satisfies something primal in me. This is what I fought for when I fled arranged marriage in Italy, slipping out of my family’s estate with just a backpack.
This chosen family, these broken pieces fitting together into something stronger than any traditional pack. Not a textbook illustration but a living creation defying categories.
“You should be resting too.”
Malachi’s voice carries concern from the doorway. Quinn’s alpha commands Omega Guardians with steady hand and strategic vision—the perfect complement to Aria’s passionate leadership. His scent carries authority without dominance.
“I’m fine,” I assure him, continuing my checks. “Post-heat recovery is normal.”
His expression looks skeptical. “That’s not what I meant.”
I understand his concern. My omega tendency is to overextend for pack while neglecting myself, a habit my nursing professors warned against.
But what most people don’t understand is that for me, caring for them is taking care of myself too.
“I’ll rest when they’re stable,” I promise, knowing he means well. “The symphony isn’t finished yet.”
His gaze travels across my sleeping packmates, with professional respect rather than judgment. “You’ve built something remarkable here. Something I wouldn’t have thought possible.”
The observation carries weight. Traditional groups follow strict patterns—who leads, who nurtures, who supports. What we’ve built defies those boundaries, focusing on individual strengths instead of our biology.
“We built it together,” I correct gently. “No blueprint, just necessity.”
He nods, understanding. “Mona requested your presence when you’re available. She has updates on the formula counteragent.”
“Is Finn’s condition?—”
“Stable,” he assures me. “This is about global response protocols.”
Relief flows through me, releasing tension I hadn’t noticed, my omega instincts momentarily overtaking my medical training. Despite Mona’s chaotic presentation, her scientific brilliance has proven our most valuable asset in addressing Sterling’s biological warfare. Her lab within Omega Guardians has become command central for worldwide neutralization efforts.
“I’ll go once they wake,” I promise, balancing medical responsibility against omega instinct.
Malachi leaves quietly, respecting pack space. His understanding of designation dynamics makes Omega Guardians the ideal recovery location—secure without feeling confining, medical without feeling clinical.
Cayenne stirs first, still on hacker’s schedule despite exhaustion. Her eyes open with immediate awareness—a survival adaptation I’ve noticed in all Sterling’s children. Her lemon-ozone scent sharpens, carrying those strange notes that fascinate Mona.
“Morning, piccola,” I greet softly, handing her water before she asks.
Her smile shows a rare vulnerability in these private moments. “How’s Finn?”
“Improving. Mona’s treatment is neutralizing the formula effects.” I sit beside her, automatically checking her pulse—an omega habit she tolerates with surprising patience. “How’s the headache?”
“Better.” Her gaze travels to the windows, noting security protocols in reinforced glass and monitoring systems. “Any news?”
I pass her the tablet with Quinn’s daily news compilation. The headlines continue documenting Sterling Industries’ collapse—global investigations, criminal charges against executives, research facilities seized by authorities.
“They found the London distribution center,” she notes, scanning with efficiency. “Mona’s recall codes worked.”
“Her underground network is coordinating with health agencies to identify anyone already exposed. The neutralizing agent is showing ninety-three percent effectiveness.”
She scrolls through images of Sterling facilities worldwide—each under investigation by authorities who look horrified as they discover Roman’s experimentation. The formula was just the beginning—designation manipulation on industrial scale, genetic targeting systems, identity reconstruction technologies.
“Have they found him?” she asks, the question we’ve avoided since Aurora collapsed.
“No.” I choose honesty despite the comfort of uncertainty. “The control hub was buried under three levels of reinforced concrete. Recovery operations are focusing on securing research data and containing potential biohazards.”
Her expression reveals nothing, but through our bond, I feel complex emotions—not satisfaction, not regret, something more nuanced. Her scent shifts slightly, lemon turning sharper.
“He’s either dead or trapped,” she says finally. “Either way, it’s over.”
Finn stirs at her voice, mind surfacing through medication. “Probability of survival under those conditions is about seven percent,” he contributes, eyes still closed. “Assuming independent life support and intact water recycling.”
“Ever the optimist,” Jinx mutters, stretching despite his injuries. His cherry tobacco scent intensifies with wakefulness.
“Realist,” Finn corrects, finally opening his eyes. “Statistical analysis isn’t optimism.”
“How are you feeling?” I ask, professional assessment taking priority over their banter.
Finn considers the question with characteristic precision. “Functional at about seventy-four percent. Cognitive systems near-optimal. Physical recovery proceeding as expected.”
“In normal human speak?” Cayenne prompts, fondness beneath exasperation.
“Better,” he translates with small smile. “The formula effects seem to be stabilizing rather than progressing.”
Ryker wakes last, transitioning from sleep to full alertness without intermediate stages. His commander’s assessment sweeps the room before settling on his pack. His cedar scent intensifies with wakefulness.
“Status report,” he requests, sitting up despite my disapproving look.
“Everyone’s recovering as expected,” I tell him, adjusting his shoulder dressing without asking permission. “Mona has updates on the counteragent distribution. Global response agencies have integrated her protocols into emergency management.”
His nod carries satisfaction. “Quinn’s security?”
“Full perimeter, three-layer authentication, surveillance with AI recognition software.” I’ve learned to answer his security concerns with specifics rather than general reassurance. “Also, Aria has half the Omega Guardians staff watching entrance points. An impenetrable fortress.”
His tension eases slightly—trust earned through proven reliability.
“You should see Mona,” he says, noticing the message on my tablet. “We’ll manage here.”
The suggestion carries alpha authority softened by genuine consideration. In another life, in my family’s villa where omegas were decorative property, I would have bristled at being directed. Now I recognize the care beneath the command—his way of ensuring I meet professional obligations while taking care of myself.
“Try not to undo all my medical work while I’m gone,” I request, mostly serious. “I’ve used up our supply of the good painkillers on you three.”
Jinx’s grin shows predatory edges. “No promises, piccolo.”
Omega Guardians’ research division occupies the northwest section—furthest from residential wings, designed for both security and containment. Mona has transformed their primary laboratory into a chaotic scientific kingdom that somehow functions with terrifying efficiency.
I find her surrounded by holographic displays showing formula distribution maps, test results, and statistical models. Her typical manic energy has focused—still chaotic but channeled toward specific purpose. Her oleander scent carries notes of determination beneath chemical undertones from her work.
“Theo!” she exclaims, spinning toward me abruptly. “Progress report. Much success. Very scientific validation.”
Despite her fragmented speech, the data surrounding her tells a coherent story—Sterling’s formula neutralized in over eighty percent of distributed batches, affected individuals receiving successful treatment, statistical projection showing complete containment within two weeks.
“The pack doing well?” she asks, attention already divided between our conversation and three separate calculation models. “Finn’s rejection cascade particularly interesting. Very unusual immunological response.”
“He’s stable,” I confirm, studying the medical data with professional interest. “The treatment protocol is working.”
“Obviously.” Her pride shows no false modesty. “Designed specifically for Sterling formula molecular structure. Very precise targeting. Much scientific elegance.”
The laboratory door opens, admitting Aria with tablet in hand. Her usual vibrant energy has tempered with exhaustion from coordinating worldwide response efforts, but satisfaction radiates from her. Her floral scent carries notes of accomplishment despite lingering stress.
“You need to see this,” she says, activating the main display screen.
International news broadcast fills the wall—press conference where government officials stand alongside former Sterling scientists now providing evidence. The headline scrolls beneath in multiple languages: GLOBAL INVESTIGATION REVEALS UNAUTHORIZED DESIGNATION MANIPULATION PROGRAM.
“They’re exposing everything,” Aria explains, voice tight with emotion. “Not just the formula but the entire operation—designation trafficking, illegal experimentation, omega modification programs.”
The broadcast shifts to footage of underground facilities being raided—hidden research sites where test subjects were held, beta “treatment centers” serving as unwitting experimental stations, omega “enhancement” clinics performing unauthorized genetic modifications.
“My network,” Mona whispers, rare genuine emotion breaking through her chaotic facade. Her oleander scent sharpens with something almost like pride. “They found them.”
It clicks—the coordinates Mona provided investigators are yielding results, exposing not just Sterling’s crimes but the underground resistance she built over years of patient sabotage.
“The Beta treatment centers in Seattle and Prague have been secured,” Aria continues, scrolling through updates. “Subjects receiving medical intervention. Sterling’s executive board facing criminal charges in seventeen countries.”
The broadcast shifts to a press conference where a familiar face appears—Marcus, the security guard who helped us infiltrate Aurora. He speaks about his beta sister held in Sterling’s research program, his voice steady despite the horror he describes.
“They’re all coming forward,” Aria says, voice thick with emotion. “Guards, researchers, test subjects—everyone Roman threatened or blackmailed into silence. It’s like a dam breaking.”
Mona’s typical manic movement stills completely—a rare moment of stillness as she watches the world acknowledge the resistance she built piece by piece over years of patient sabotage.
“How many?” I ask.
“Eighty-seven facilities worldwide,” she answers, precision suggesting these numbers are burned into her memory. “Forty-three underground networks. Two hundred seventeen resistance operatives.”
It hits me then—just how far she’s reached. Not sabotage. Not revenge. A resistance network built across borders, through castes and codes. All of it seeded by the omega Roman thought he’d shattered. She wasn’t broken. She was building.
“You did this,” I say, recognition carrying genuine awe. “All these years. You were dismantling him from the inside.”
Her smile carries none of its usual manic energy—something quieter, more genuine, almost painful in its sincerity. “Not just me. Alexander helped.” A pause, something vulnerable crossing her expression. “And Emma inspired it all.”
The name strikes a chord—Jinx’s sister who died too young, the one he rarely mentions but with such raw emotion. I remember him telling Cayenne that Mona reminded him of Emma in her brilliance. Emma might be gone, but her spirit lived on in what Mona had built. The connection suddenly makes more sense.
My tablet chimes with an urgent alert from the recovery suite. Before I can check it, Mona’s already responding to her own devices, oleander scent spiking with alarm.
“Formula progression. Unexpected activity pattern.” Her tone shifts instantly from emotional to clinical. “Need to go. Now.”
We rush back toward the recovery wing, Mona moving surprisingly fast for someone in platform boots and an oversized lab coat. Her oleander scent sharpens with scientific focus.
“What’s happening?” I ask, struggling to keep pace.
“Secondary cascade. Neural reconfiguration accelerating.” Her explanations come in fragments. “Finn’s beta system unsuitable for formula progression. Potential catastrophic rejection event.”
When we reach the recovery suite, I immediately sense the crisis—the air thick with distress pheromones, medical alarms blaring. Finn’s body is rigid, back arching as violent tremors rack through him. The purple veins along his arms have darkened to an almost black, spreading visibly across his pale skin.
Cayenne is already at his side, trying to stabilize him while Ryker communicates with medical response teams. Jinx has positioned himself at the door, securing the perimeter.
“What’s happening?” Cayenne demands, her scent sharp with fear as she holds Finn’s shoulders.
“The formula’s progressing,” I explain, already moving to administer emergency counteragents. “It’s attacking his central nervous system.”
The door bursts open as Quinn’s medical team rushes in, equipment filling our carefully constructed recovery space. But before they can reach Finn, Mona charges forward, scattering them with surprising authority for someone her size.
“Move! Inefficient medical response! Much wasted motion!” She pushes past the team, tablets balanced in her arms. “Formula progression entering phase two. Neural reconfiguration cascade.”
Quinn’s chief medical officer starts to protest. “Dr. Sterling, protocol requires?—”
“Protocol inadequate. Sterling formula beyond standard medical parameters.” She’s already hooking up specialized equipment to Finn’s monitors. “Need specialized intervention. My design. My understanding.”
The medical team exchanges uncertain glances, but Quinn nods from the doorway. “Do what she says.”
Mona works with frantic efficiency, fingers flying across tablets while simultaneously adjusting IV medications and monitoring neural responses. “Secondary cascade triggering prematurely. Very concerning progression. Much accelerated timeline.”
“Is he dying?” Cayenne asks directly, her voice steady despite the fear pulsing through our bond.
“Not acceptable outcome,” Mona responds without looking up. “Won’t allow it. Too much data collection investment. Also, significant emotional attachment variable.” She pauses briefly, something almost human crossing her expression. “He’s pack-adjacent. Important.”
Through our bond, I feel Finn’s presence flickering—not disappearing, but changing frequency like a signal being disrupted. The purple-black lines spread visibly along his veins, tracing patterns that follow no known anatomical structure.
“Chemical stabilizers ineffective,” Mona mutters, discarding one approach and immediately starting another. “Need counteragent recalibration.” She looks up suddenly. “Blood. Need Sterling blood. Compatible antigens. Genetic resistance factors.”
“Mine?” Cayenne is already rolling up her sleeve.
“Optimal donor. Similar viral exposure pattern. Enhanced resistance metrics.” Mona snaps her fingers at a nurse. “Blood draw. Rapid stabilization protocol.”
As the nurse prepares Cayenne for the blood draw, Mona turns to the rest of us. “Need space. Too many bodies. Inefficient respiratory pattern. Bad air circulation dynamics.”
“We’re not leaving him,” Jinx growls, cherry tobacco scent sharpening with protective fury.
“Not suggested. Merely relocate. Three-meter perimeter. Maintain pack bond. Important stabilization factor.” She’s already turning back to her equipment. “Pack bonds demonstrating unexpected physiological impact. Very interesting data. Much research potential.”
I guide the pack back, creating the distance Mona needs while keeping us within range to maintain our connection to Finn. Through the bond, I feel his analytical presence struggling to maintain coherence as the formula attacks his neural pathways.
“I’ve never seen anything like this,” Quinn’s medical officer whispers, watching the dark lines spread across Finn’s skin.
“No one has,” I respond quietly. “Roman designed this formula as a weapon. It was never meant to heal, but to control.”
Mona works with terrifying intensity, her movements a blur of calculated chaos. The transfusion of Cayenne’s blood begins, and monitors immediately register a response—subtle but measurable.
“Stabilization beginning,” Mona announces without looking up. “Sterling genetic markers providing temporary resistance framework.”
“Will he recover?” Ryker asks, cedar scent sharp with concern beneath his commander’s calm.
“Unknown. Formula designed for omega-adjacent genetic structure.” Mona glances briefly at Cayenne. “Beta physiology lacking necessary receptors. Creating unprecedented neural pathways.”
“What does that mean?” Cayenne presses.
Mona finally pauses, looking up from her instruments with rare directness. “Means if he survives, he won’t be the same. Formula rewrites designation at fundamental level. Changes... everything.”
The revelation settles over us like physical weight. Not just a matter of recovery time, but potential transformation at the most fundamental level.
“Will he still be Finn?” Cayenne asks, the question we’re all afraid to voice.
“Core personality structures likely stable. Analytical processes potentially enhanced.” Mona returns to her work. “But designation markers in flux. Impossible to predict final configuration.”
As we watch Mona fight to stabilize him, I feel something shift in our pack dynamics—the easy relief of victory giving way to the stark reality that Roman Sterling’s legacy continues to threaten us even from beneath tons of concrete.
The battle for Aurora may be won, but the war for Finn’s survival is just beginning.